Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York State Psychiatric Institute |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00084188 |
The purpose of this study is to look at a program for women in drug abuse treatment designed to reduce Human Immunodeficiency Virus/Sexually Transmitted Disease (HIV/STD) risk behaviors and reduce unprotected sexual risk behavior.
Condition | Intervention | Phase |
---|---|---|
Behavior Therapy |
Behavioral: Behavior Therapy |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs |
Estimated Enrollment: | 541 |
Study Start Date: | May 2004 |
Study Completion Date: | October 2005 |
Primary Completion Date: | October 2005 (Final data collection date for primary outcome measure) |
The proposed trial is intended to test the effectiveness of a proven, manual driven, five-session safer sexual skills building group (SSB) intervention (Schilling et al., 1991; El Bassel and Schilling, 1992) for female patients in MMTP or in drug-free outpatient treatment. The effects of SSB will be compared to a standard group HIV education session (HE).
This study uses a 2-group, randomized, parallel-group design to compare a five-session safer sexual skills building group to a single 60-min HIV education session (control condition). The control condition is designed to standardize and simulate the usual care at community clinics.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Adult females (18 years of age or older) in drug abuse treatment at participating Community Treatment Programs are invited to participate.
United States, California | |
BAART CDP | |
Los Angeles, California, United States, 90057 | |
United States, Connecticut | |
Hartford Dispensary | |
New Britain, Connecticut, United States, 06051 | |
United States, New York | |
Staten Island University Hospital | |
Staten Island, New York, United States, 10309 | |
United States, North Carolina | |
South Light - Wakeview | |
Raleigh, North Carolina, United States, 27604 | |
South Light - Life Plus | |
Raleigh, North Carolina, United States, 27604 | |
Addiction Drug Services | |
Greensboro, North Carolina, United States, 27401 | |
United States, Ohio | |
Comprehensive Addiction Services System | |
Toledo, Ohio, United States, 43620 | |
United States, Pennsylvania | |
The Consortium | |
Philadelphia, Pennsylvania, United States, 19104 | |
Thomas Jefferson Intensive Sub. Abuse TP | |
Philadelphia, Pennsylvania, United States, 19107 | |
United States, South Carolina | |
LRADAC-Lexington-Richmond Alcohol & Drug Council | |
Columbia, South Carolina, United States, 29204 | |
United States, Washington | |
Evergreen Treatment Services | |
Seattle, Washington, United States, 98134 1618 | |
United States, West Virginia | |
Prestera Center for Mental Health Svcs. | |
Huntington, West Virginia, United States, 25704 |
Principal Investigator: | Susan Tross, Ph.D. | New York State Psychiatric Institute |
Study ID Numbers: | NIDA-CTN-0019-1 |
Study First Received: | June 8, 2004 |
Last Updated: | July 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00084188 |
Health Authority: | United States: Federal Government |
HIV Infections Acquired Immunodeficiency Syndrome |